According to our (Global Info Research) latest study, the global Long-acting and Short-acting Oral Contraceptives market size was valued at US$ 667 million in 2024 and is forecast to a readjusted size of USD 831 million by 2031 with a CAGR of 3.2% during review period.
Oral contraceptives (birth control pills) are hormone-containing medications that are taken by mouth to prevent pregnancy. They prevent pregnancy by inhibiting ovulation and also by preventing sperm from penetrating through the cervix.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Long-acting and Short-acting Oral Contraceptives market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Long-acting and Short-acting Oral Contraceptives market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Long-acting and Short-acting Oral Contraceptives market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Long-acting and Short-acting Oral Contraceptives market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Long-acting and Short-acting Oral Contraceptives market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Long-acting and Short-acting Oral Contraceptives
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Long-acting and Short-acting Oral Contraceptives market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Paladin Labs, Theramex (Teva), Pfizer, Apotex, HRA Pharma, HLL Life Care, Mankind, Piramal, Allergan, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Long-acting and Short-acting Oral Contraceptives market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Combined Contraceptive Pill
Low Dose Oral Contraceptive
Market segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce
Major players covered
Bayer
Paladin Labs
Theramex (Teva)
Pfizer
Apotex
HRA Pharma
HLL Life Care
Mankind
Piramal
Allergan
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Long-acting and Short-acting Oral Contraceptives product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Long-acting and Short-acting Oral Contraceptives, with price, sales quantity, revenue, and global market share of Long-acting and Short-acting Oral Contraceptives from 2020 to 2025.
Chapter 3, the Long-acting and Short-acting Oral Contraceptives competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Long-acting and Short-acting Oral Contraceptives breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Long-acting and Short-acting Oral Contraceptives market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Long-acting and Short-acting Oral Contraceptives.
Chapter 14 and 15, to describe Long-acting and Short-acting Oral Contraceptives sales channel, distributors, customers, research findings and conclusion.
- 1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Long-acting and Short-acting Oral Contraceptives Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Combined Contraceptive Pill
- 1.3.3 Low Dose Oral Contraceptive
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Long-acting and Short-acting Oral Contraceptives Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Hospital Pharmacies
- 1.4.3 Private Clinics
- 1.4.4 Retail Pharmacies
- 1.4.5 E-Commerce
- 1.5 Global Long-acting and Short-acting Oral Contraceptives Market Size & Forecast
- 1.5.1 Global Long-acting and Short-acting Oral Contraceptives Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Long-acting and Short-acting Oral Contraceptives Sales Quantity (2020-2031)
- 1.5.3 Global Long-acting and Short-acting Oral Contraceptives Average Price (2020-2031)
- 2 Manufacturers Profiles
- 2.1 Bayer
- 2.1.1 Bayer Details
- 2.1.2 Bayer Major Business
- 2.1.3 Bayer Long-acting and Short-acting Oral Contraceptives Product and Services
- 2.1.4 Bayer Long-acting and Short-acting Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Bayer Recent Developments/Updates
- 2.2 Paladin Labs
- 2.2.1 Paladin Labs Details
- 2.2.2 Paladin Labs Major Business
- 2.2.3 Paladin Labs Long-acting and Short-acting Oral Contraceptives Product and Services
- 2.2.4 Paladin Labs Long-acting and Short-acting Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Paladin Labs Recent Developments/Updates
- 2.3 Theramex (Teva)
- 2.3.1 Theramex (Teva) Details
- 2.3.2 Theramex (Teva) Major Business
- 2.3.3 Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Product and Services
- 2.3.4 Theramex (Teva) Long-acting and Short-acting Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Theramex (Teva) Recent Developments/Updates
- 2.4 Pfizer
- 2.4.1 Pfizer Details
- 2.4.2 Pfizer Major Business
- 2.4.3 Pfizer Long-acting and Short-acting Oral Contraceptives Product and Services
- 2.4.4 Pfizer Long-acting and Short-acting Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Pfizer Recent Developments/Updates
- 2.5 Apotex
- 2.5.1 Apotex Details
- 2.5.2 Apotex Major Business
- 2.5.3 Apotex Long-acting and Short-acting Oral Contraceptives Product and Services
- 2.5.4 Apotex Long-acting and Short-acting Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Apotex Recent Developments/Updates
- 2.6 HRA Pharma
- 2.6.1 HRA Pharma Details
- 2.6.2 HRA Pharma Major Business
- 2.6.3 HRA Pharma Long-acting and Short-acting Oral Contraceptives Product and Services
- 2.6.4 HRA Pharma Long-acting and Short-acting Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 HRA Pharma Recent Developments/Updates
- 2.7 HLL Life Care
- 2.7.1 HLL Life Care Details
- 2.7.2 HLL Life Care Major Business
- 2.7.3 HLL Life Care Long-acting and Short-acting Oral Contraceptives Product and Services
- 2.7.4 HLL Life Care Long-acting and Short-acting Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 HLL Life Care Recent Developments/Updates
- 2.8 Mankind
- 2.8.1 Mankind Details
- 2.8.2 Mankind Major Business
- 2.8.3 Mankind Long-acting and Short-acting Oral Contraceptives Product and Services
- 2.8.4 Mankind Long-acting and Short-acting Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.8.5 Mankind Recent Developments/Updates
- 2.9 Piramal
- 2.9.1 Piramal Details
- 2.9.2 Piramal Major Business
- 2.9.3 Piramal Long-acting and Short-acting Oral Contraceptives Product and Services
- 2.9.4 Piramal Long-acting and Short-acting Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.9.5 Piramal Recent Developments/Updates
- 2.10 Allergan
- 2.10.1 Allergan Details
- 2.10.2 Allergan Major Business
- 2.10.3 Allergan Long-acting and Short-acting Oral Contraceptives Product and Services
- 2.10.4 Allergan Long-acting and Short-acting Oral Contraceptives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.10.5 Allergan Recent Developments/Updates
- 3 Competitive Environment: Long-acting and Short-acting Oral Contraceptives by Manufacturer
- 3.1 Global Long-acting and Short-acting Oral Contraceptives Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Long-acting and Short-acting Oral Contraceptives Revenue by Manufacturer (2020-2025)
- 3.3 Global Long-acting and Short-acting Oral Contraceptives Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Long-acting and Short-acting Oral Contraceptives by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Long-acting and Short-acting Oral Contraceptives Manufacturer Market Share in 2024
- 3.4.3 Top 6 Long-acting and Short-acting Oral Contraceptives Manufacturer Market Share in 2024
- 3.5 Long-acting and Short-acting Oral Contraceptives Market: Overall Company Footprint Analysis
- 3.5.1 Long-acting and Short-acting Oral Contraceptives Market: Region Footprint
- 3.5.2 Long-acting and Short-acting Oral Contraceptives Market: Company Product Type Footprint
- 3.5.3 Long-acting and Short-acting Oral Contraceptives Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
- 4 Consumption Analysis by Region
- 4.1 Global Long-acting and Short-acting Oral Contraceptives Market Size by Region
- 4.1.1 Global Long-acting and Short-acting Oral Contraceptives Sales Quantity by Region (2020-2031)
- 4.1.2 Global Long-acting and Short-acting Oral Contraceptives Consumption Value by Region (2020-2031)
- 4.1.3 Global Long-acting and Short-acting Oral Contraceptives Average Price by Region (2020-2031)
- 4.2 North America Long-acting and Short-acting Oral Contraceptives Consumption Value (2020-2031)
- 4.3 Europe Long-acting and Short-acting Oral Contraceptives Consumption Value (2020-2031)
- 4.4 Asia-Pacific Long-acting and Short-acting Oral Contraceptives Consumption Value (2020-2031)
- 4.5 South America Long-acting and Short-acting Oral Contraceptives Consumption Value (2020-2031)
- 4.6 Middle East & Africa Long-acting and Short-acting Oral Contraceptives Consumption Value (2020-2031)
- 5 Market Segment by Type
- 5.1 Global Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2020-2031)
- 5.2 Global Long-acting and Short-acting Oral Contraceptives Consumption Value by Type (2020-2031)
- 5.3 Global Long-acting and Short-acting Oral Contraceptives Average Price by Type (2020-2031)
- 6 Market Segment by Application
- 6.1 Global Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2020-2031)
- 6.2 Global Long-acting and Short-acting Oral Contraceptives Consumption Value by Application (2020-2031)
- 6.3 Global Long-acting and Short-acting Oral Contraceptives Average Price by Application (2020-2031)
- 7 North America
- 7.1 North America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2020-2031)
- 7.2 North America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2020-2031)
- 7.3 North America Long-acting and Short-acting Oral Contraceptives Market Size by Country
- 7.3.1 North America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Country (2020-2031)
- 7.3.2 North America Long-acting and Short-acting Oral Contraceptives Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
- 8 Europe
- 8.1 Europe Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2020-2031)
- 8.2 Europe Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2020-2031)
- 8.3 Europe Long-acting and Short-acting Oral Contraceptives Market Size by Country
- 8.3.1 Europe Long-acting and Short-acting Oral Contraceptives Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Long-acting and Short-acting Oral Contraceptives Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
- 9 Asia-Pacific
- 9.1 Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Long-acting and Short-acting Oral Contraceptives Market Size by Region
- 9.3.1 Asia-Pacific Long-acting and Short-acting Oral Contraceptives Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Long-acting and Short-acting Oral Contraceptives Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
- 10 South America
- 10.1 South America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2020-2031)
- 10.2 South America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2020-2031)
- 10.3 South America Long-acting and Short-acting Oral Contraceptives Market Size by Country
- 10.3.1 South America Long-acting and Short-acting Oral Contraceptives Sales Quantity by Country (2020-2031)
- 10.3.2 South America Long-acting and Short-acting Oral Contraceptives Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
- 11 Middle East & Africa
- 11.1 Middle East & Africa Long-acting and Short-acting Oral Contraceptives Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Long-acting and Short-acting Oral Contraceptives Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Long-acting and Short-acting Oral Contraceptives Market Size by Country
- 11.3.1 Middle East & Africa Long-acting and Short-acting Oral Contraceptives Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Long-acting and Short-acting Oral Contraceptives Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
- 12 Market Dynamics
- 12.1 Long-acting and Short-acting Oral Contraceptives Market Drivers
- 12.2 Long-acting and Short-acting Oral Contraceptives Market Restraints
- 12.3 Long-acting and Short-acting Oral Contraceptives Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 13 Raw Material and Industry Chain
- 13.1 Raw Material of Long-acting and Short-acting Oral Contraceptives and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Long-acting and Short-acting Oral Contraceptives
- 13.3 Long-acting and Short-acting Oral Contraceptives Production Process
- 13.4 Industry Value Chain Analysis
- 14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Long-acting and Short-acting Oral Contraceptives Typical Distributors
- 14.3 Long-acting and Short-acting Oral Contraceptives Typical Customers
- 15 Research Findings and Conclusion
- 16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
- 16.3 Disclaimer
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook